---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-26-000060"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2026-10-09T21:19:26+00:00"
generated_at: "2026-10-12T14:58:00.881855+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics eliminates Series A Preferred stock designation after all shares convert to common

## Summary
- Certificate of Elimination filed with Delaware Secretary of State on October 5, 2026, removing all Series A Convertible Preferred terms from the charter.
- Series A Certificate of Designations originally filed April 10, 2025, and corrected May 22, 2025; no Series A Preferred shares remain outstanding.
- All issued Series A Preferred converted into common stock, and none will be issued; eliminated shares revert to authorized but unissued undesignated preferred stock.

## SEC filing metadata
- accession: 0001708599-26-000060
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2026-10-09T21:19:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/0001708599-26-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/ser-20261005.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-26-000060
- JSON: https://secwatch.observer/filing/0001708599-26-000060.json
- Plain text: https://secwatch.observer/filing/0001708599-26-000060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.